Drugs / MSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07465198 | Sep 2026 → Sep 2029 expected | multiple system atrophy | Biocells Medical | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07465198 ↗ |
| Modality | Cell therapy | “autologous stem cell therapy” NCT07465198 ↗ |
| Route | Intravenous | “IV infusion” NCT07465198 ↗ |